Pharmaceuticals.jpg

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

59865-13-3

Cyclosporin A

59865-13-3
51481-61-9

Cimetidine

51481-61-9
78439-06-2

Ceftazidime pentahydrate with10% Na2CO3

78439-06-2
105956-97-6

Clinafloxacin

105956-97-6
78072-66-9

Caffeine-13C3

78072-66-9
113665-84-2

Clopidogrel Sulfate

113665-84-2
169590-42-5

Celecoxib

169590-42-5
6004-24-6

Cetylpyridinium chloride H2O

6004-24-6
24356-60-3

Cefapirin sodium

24356-60-3
26097-80-3

Cambendazole

26097-80-3
55-56-1

Chlorhexidine

55-56-1
58-71-9

Cephalothin sodium salt

58-71-9
1093-58-9

Clostebol

1093-58-9
5439-87-2

Carbocisteine Sulfoxide (Mixture of diastereomers)

5439-87-2
88933-48-6

Carbocisteine Lactam Sodium Salt

88933-48-6
64806-05-9

Captopril Disulfide

64806-05-9
112-02-7

Cetrimonium chloride

112-02-7
15307-79-6

Diclofenac sodium

15307-79-6
19408-84-5

Dihydrocapsaicin

19408-84-5
439-14-5

Diazepam C-IV

439-14-5